CYP2D6 and atrial fibrillation: Notably, the observed frequency of CYP2D6*41 in our SSA cohorts (AF = 0.8%) was significantly less than the average frequency (11.5%) calculated by the PharmGKB from previous studies in the region (see https://www.pharmgkb.org/page/cyp2d6RefMaterials).